| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | photoreceptor outer segment | 9.91e-05 | 111 | 139 | 6 | GO:0001750 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EPRS1 IMPDH2 ATRX DNAH10 ACAT1 ACAD9 VPS13C PARK7 RGS22 UGGT1 RPS11 HMGB1 HMGCL CHD4 SSB XPO1 HNRNPAB PAICS ACTR3 TUFM EEF1B2 DDX50 FANCI SUPT16H PWP2 EIF3B TALDO1 RPL4 DDX39B XRCC6 FTSJ3 | 1.07e-14 | 1425 | 140 | 31 | 30948266 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EPRS1 IMPDH2 PARK7 UGGT1 RPS11 DNAJB4 HMGB1 EWSR1 CHD4 SSB XPO1 HNRNPAB PAICS ACTR3 TUFM EEF1B2 IGF2BP3 FANCI AHNAK SUPT16H EIF3B HCFC2 TALDO1 RPL4 DDX39B XRCC6 PACSIN2 FTSJ3 | 1.60e-14 | 1149 | 140 | 28 | 35446349 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EPRS1 IMPDH2 UBE4B ACAT1 PARK7 RPS11 CHD4 VPS16 XPO1 BIRC6 HNRNPAB PAICS ACTR3 TUFM FAM83H POLR1F EEF1B2 PTPN12 DDX50 FANCI SGPL1 AHNAK SUPT16H EIF3B HERC2 RPL4 DDX39B HSPB8 XRCC6 FTSJ3 | 1.89e-14 | 1353 | 140 | 30 | 29467282 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | EPRS1 IMPDH2 ACAT1 RBBP6 RPS11 HMGB1 EWSR1 CHD4 SSB HNRNPAB PAICS ACTR3 TUFM FAM83H POLR1F EEF1B2 IGF2BP3 DDX50 AHNAK SUPT16H PWP2 EIF3B MORC3 TALDO1 RPL4 DDX39B XRCC6 FTSJ3 | 4.53e-13 | 1318 | 140 | 28 | 30463901 |
| Pubmed | EPRS1 IMPDH2 ACAT1 RPS11 HMGB1 EWSR1 CHD4 SSB XPO1 HNRNPAB PAICS ACTR3 TUFM EEF1B2 IGF2BP3 AHNAK EIF3B TALDO1 RPL4 DDX39B XRCC6 | 1.08e-12 | 707 | 140 | 21 | 19738201 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | RNASEH2B EPRS1 IMPDH2 UBE4B UGGT1 RPS11 DNAJB4 SSB XPO1 BIRC6 HNRNPAB PAICS ACTR3 TUFM EEF1B2 UBE2R2 IGF2BP3 PTPN12 FANCI AHNAK SUPT16H EIF3B HERC1 TALDO1 DDX39B XRCC6 PACSIN2 PUS7 | 4.78e-12 | 1455 | 140 | 28 | 22863883 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | EPRS1 IMPDH2 RBBP6 UGGT1 RPS11 HMGB1 EWSR1 XPO1 HNRNPAB PAICS ACTR3 TUFM FAM83H EEF1B2 DDX50 SGPL1 AHNAK SUPT16H PWP2 EIF3B GAPDHS RPL4 DDX39B XRCC6 NOL8 FTSJ3 | 6.34e-12 | 1257 | 140 | 26 | 36526897 |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | EPRS1 IMPDH2 ACAT1 RPS11 SSB XPO1 HNRNPAB PAICS ACTR3 TUFM EEF1B2 IGF2BP3 DDX50 SUPT16H EIF3B GAPDHS TALDO1 RPL4 DDX39B XRCC6 | 1.13e-11 | 714 | 140 | 20 | 28302793 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | EPRS1 ABCA2 ACAT1 PARK7 SPTA1 UGGT1 RPS11 HMGB1 EWSR1 CHD4 CLSTN2 PAICS ACTR3 TUFM EEF1B2 AHNAK EIF3B PALS2 TALDO1 RPL4 XRCC6 | 1.30e-11 | 807 | 140 | 21 | 30575818 |
| Pubmed | EPRS1 IMPDH2 UGGT1 RPS11 EWSR1 SSB XPO1 HNRNPAB PAICS EEF1B2 IGF2BP3 AHNAK SUPT16H EIF3B TALDO1 RPL4 XRCC6 | 1.86e-11 | 494 | 140 | 17 | 26831064 | |
| Pubmed | IMPDH2 ACAT1 UGGT1 EWSR1 CHD4 SSB XPO1 BIRC6 PAICS ACTR3 TUFM IGF2BP3 FANCI AHNAK PWP2 HERC2 RPL4 XRCC6 FTSJ3 | 2.01e-11 | 653 | 140 | 19 | 22586326 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPRS1 IMPDH2 ACAT1 UGGT1 RPS11 EWSR1 CHD4 XPO1 HNRNPAB ACTR3 TUFM FAM83H EEF1B2 IGF2BP3 DDX50 AHNAK SUPT16H PWP2 EIF3B HERC2 DDX39B XRCC6 FTSJ3 | 2.40e-11 | 1024 | 140 | 23 | 24711643 |
| Pubmed | ANKRD35 EPRS1 IMPDH2 RBBP6 WFS1 PARK7 WWP2 RPS11 HMGB1 EWSR1 CHD4 SSB XPO1 ACTR3 TUFM FAM83H EEF1B2 IGF2BP3 EIF3B CAMSAP2 TALDO1 RPL4 DDX39B XRCC6 FTSJ3 | 3.31e-11 | 1247 | 140 | 25 | 27684187 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | EPRS1 ERCC5 IMPDH2 PARK7 UGGT1 RPS11 DNAJB4 EWSR1 PDCD2L CHD4 SSB XPO1 BIRC6 HNRNPAB PAICS TUFM EEF1B2 IGF2BP3 AHNAK SUPT16H EIF3B RPL4 DDX39B XRCC6 PUS7 FTSJ3 | 8.47e-11 | 1415 | 140 | 26 | 28515276 |
| Pubmed | EPRS1 RPS11 DNAJB4 CHD4 SSB XPO1 HNRNPAB PAICS TUFM FAM83H FANCI SUPT16H PWP2 EIF3B DNAJB5 RPL4 DDX39B XRCC6 | 1.17e-10 | 638 | 140 | 18 | 33239621 | |
| Pubmed | EPRS1 ERCC5 ATRX PCDHGB5 SPTA1 UGGT1 RPS11 HMGB1 HMGCL CHD4 HNRNPAB ACTR3 TUFM RYR2 EEF1B2 SHANK2 DDX50 SCG3 AHNAK SUPT16H PWP2 CAMSAP2 RPL4 DDX39B XRCC6 CFAP46 | 1.27e-10 | 1442 | 140 | 26 | 35575683 | |
| Pubmed | EPRS1 RBBP6 RPS11 EXOSC1 EWSR1 CHD4 SSB XPO1 HNRNPAB PAICS EEF1B2 IGF2BP3 DDX50 SGPL1 PWP2 EIF3B HCFC2 RPL4 NOL8 FTSJ3 | 2.29e-10 | 847 | 140 | 20 | 35850772 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | IMPDH2 ACAT1 SGCD RPS11 EWSR1 CHD4 XPO1 HNRNPAB PAICS TUFM POLR1F DDX50 FANCI AHNAK SUPT16H PWP2 RPL4 DDX39B XRCC6 NOL8 FTSJ3 | 5.32e-10 | 989 | 140 | 21 | 36424410 |
| Pubmed | EPRS1 SORBS2 ACAT1 WFS1 PARK7 SPTA1 RPS11 HMGB1 NCAM2 EWSR1 SSB GRIN2B XPO1 HNRNPAB NDUFC2 ACTR3 TUFM MAGI2 EEF1B2 SHANK2 SGPL1 PRKAG2 CAMSAP2 RPL4 DDX39B | 5.83e-10 | 1431 | 140 | 25 | 37142655 | |
| Pubmed | EPRS1 IMPDH2 ACAT1 RPS11 HMGB1 EWSR1 CHD4 SSB XPO1 HNRNPAB TUFM EEF1B2 IGF2BP3 SUPT16H EIF3B RPL4 DDX39B XRCC6 | 6.57e-10 | 711 | 140 | 18 | 33022573 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | EPRS1 IMPDH2 UGGT1 SALL4 XPO1 TUFM AHNAK SUPT16H HERC2 RPL4 XRCC6 | 6.81e-10 | 202 | 140 | 11 | 33005030 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EPRS1 IMPDH2 ATRX RBBP6 PARK7 RPS11 PDCD2L CHD4 HNRNPAB EEF1B2 IGF2BP3 PTPN12 DDX50 AHNAK CAMSAP2 RPL4 XRCC6 PUS7 NOL8 FTSJ3 | 1.24e-09 | 934 | 140 | 20 | 33916271 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | EPRS1 ATRX ACAT1 RBBP6 HMGB1 EWSR1 CHD4 HNRNPAB HMGB1P1 POLR1F EEF1B2 DDX50 FANCI AHNAK SUPT16H PWP2 DDX39B XRCC6 NOL8 FTSJ3 | 1.78e-09 | 954 | 140 | 20 | 36373674 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | EPRS1 IMPDH2 ATRX ACAT1 UGGT1 RPS11 EWSR1 SSB LCN1 HNRNPAB PAICS ACTR3 TUFM MAGI2 EEF1B2 IGF2BP3 FANCI WRAP73 ASXL2 GAPDHS HERC2 HERC1 FTSJ3 | 1.94e-09 | 1284 | 140 | 23 | 17353931 |
| Pubmed | IMPDH2 ACAT1 RBBP6 ACAD9 PARK7 UGGT1 RPS11 DNAJB4 HMGB1 PDCD2L XPO1 BIRC6 HNRNPAB PAICS EEF1B2 IGF2BP3 FAT1 PTPN12 DDX50 AHNAK MRPL38 RPL4 XRCC6 | 2.35e-09 | 1297 | 140 | 23 | 33545068 | |
| Pubmed | EPRS1 ATRX RPS11 CHD4 HNRNPAB PAICS TUFM IGF2BP3 DDX50 EIF3B RPL4 DDX39B XRCC6 FTSJ3 | 3.45e-09 | 441 | 140 | 14 | 31239290 | |
| Pubmed | EPRS1 IMPDH2 PARK7 HMGB1 HNRNPAB PAICS TUFM AHNAK TALDO1 DDX39B XRCC6 | 3.99e-09 | 239 | 140 | 11 | 26641092 | |
| Pubmed | EPRS1 IMPDH2 ACAD9 PARK7 EWSR1 CHD4 SSB XPO1 BIRC6 PAICS ACTR3 IGF2BP3 FANCI SGPL1 TALDO1 | 4.82e-09 | 534 | 140 | 15 | 35032548 | |
| Pubmed | IMPDH2 ATRX ACAT1 RBBP6 PARK7 DNAJB4 HMGB1 CHD4 XPO1 TUFM POLR1F EEF1B2 FANCI AHNAK SUPT16H PWP2 EIF3B TALDO1 XRCC6 PUS7 | 4.98e-09 | 1014 | 140 | 20 | 32416067 | |
| Pubmed | EPRS1 RBBP6 RPS11 EXOSC1 EWSR1 CHD4 SSB HNRNPAB TUFM IGF2BP3 DDX50 SUPT16H PWP2 EIF3B RPL4 XRCC6 FTSJ3 | 7.15e-09 | 731 | 140 | 17 | 29298432 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | EPRS1 IMPDH2 UBE4B CHD4 SSB LCN1 PAICS TUFM IGF2BP3 AHNAK SUPT16H EIF3B DDX39B XRCC6 | 9.31e-09 | 477 | 140 | 14 | 31300519 |
| Pubmed | ATRX RBBP6 RPS11 APOA2 CHD4 LCN1 HNRNPAB TUFM IGF2BP3 DDX50 FANCI AHNAK SUPT16H RPL4 DDX39B XRCC6 | 9.67e-09 | 652 | 140 | 16 | 31180492 | |
| Pubmed | IMPDH2 ACAT1 PARK7 RPS11 SSB HNRNPAB PAICS ACTR3 TUFM RPL4 DDX39B XRCC6 | 9.71e-09 | 327 | 140 | 12 | 34428256 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | IMPDH2 RBBP6 CHD4 SSB XPO1 BIRC6 HNRNPAB POLR1F IGF2BP3 DDX50 SUPT16H PWP2 HERC2 RPL4 XRCC6 NOL8 FTSJ3 | 1.24e-08 | 759 | 140 | 17 | 35915203 |
| Pubmed | 1.38e-08 | 208 | 140 | 10 | 11790298 | ||
| Pubmed | Blocking an N-terminal acetylation-dependent protein interaction inhibits an E3 ligase. | IMPDH2 ACAT1 PARK7 UGGT1 RPS11 EWSR1 SSB HNRNPAB PAICS EEF1B2 EIF3B RPL4 DDX39B XRCC6 | 1.48e-08 | 495 | 140 | 14 | 28581483 |
| Pubmed | 1.63e-08 | 110 | 140 | 8 | 25940091 | ||
| Pubmed | EPRS1 ABCA2 IMPDH2 ACAT1 ACAD9 PARK7 UGGT1 RPS11 EWSR1 CHD4 SSB XPO1 HNRNPAB PAICS TUFM EEF1B2 IGF2BP3 SUPT16H EIF3B RPL4 DDX39B XRCC6 | 2.03e-08 | 1335 | 140 | 22 | 29229926 | |
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | RPS11 HMGB1 EWSR1 SSB HNRNPAB TUFM DDX50 SUPT16H PWP2 RPL4 DDX39B XRCC6 FTSJ3 | 2.28e-08 | 430 | 140 | 13 | 38172120 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | EPRS1 RPS11 EWSR1 CHD4 LCN1 HNRNPAB IGF2BP3 DDX50 SUPT16H PWP2 EIF3B RPL4 DDX39B XRCC6 FTSJ3 | 2.52e-08 | 605 | 140 | 15 | 28977666 |
| Pubmed | EPRS1 IMPDH2 VPS13C PARK7 RPS11 CHD4 SSB XPO1 HNRNPAB ACTR3 TUFM EEF1B2 AHNAK TALDO1 RPL4 XRCC6 FTSJ3 | 2.81e-08 | 803 | 140 | 17 | 36517590 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | EPRS1 IMPDH2 PARK7 UGGT1 RPS11 EWSR1 SSB XPO1 BIRC6 HNRNPAB PAICS TUFM EEF1B2 IGF2BP3 FANCI WRAP73 NUB1 EIF3B RPL4 DDX39B XRCC6 | 3.50e-08 | 1257 | 140 | 21 | 37317656 |
| Pubmed | EPRS1 ACAT1 RPS11 HMGB1 EWSR1 CHD4 SSB HNRNPAB PAICS TUFM HMGB1P1 EEF1B2 IGF2BP3 DDX50 SUPT16H MRPL38 EIF3B RPL4 XRCC6 FTSJ3 | 4.17e-08 | 1153 | 140 | 20 | 29845934 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | PHF20 DNAJB4 HMGB1 HAUS3 SSB XPO1 LCN1 HNRNPAB ACTR3 FAM83H IGF2BP3 AHNAK WRAP73 ASXL2 EIF3B GNAL MORC3 HERC2 DDX39B XRCC6 | 4.29e-08 | 1155 | 140 | 20 | 20360068 |
| Pubmed | EPRS1 ABCA2 SORBS2 ATRX UBE4B NCAM2 EWSR1 CHD4 GRIN2B PAICS TMEFF1 MAGI2 SCG3 C1S MRPL38 MORC3 HERC2 TNKS2 PALS2 XRCC6 PLXNB3 | 5.08e-08 | 1285 | 140 | 21 | 35914814 | |
| Pubmed | EPRS1 IMPDH2 ACAT1 PARK7 RPS11 EWSR1 XPO1 PAICS TUFM EEF1B2 IGF2BP3 SUPT16H EIF3B GAPDHS RPL4 | 5.36e-08 | 641 | 140 | 15 | 36057605 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | EPRS1 PHF20 ATRX RBBP6 SPTA1 RPS11 EXOSC1 HMGB1 EWSR1 CHD4 HNRNPAB DDX50 AHNAK SUPT16H ASXL2 HCFC2 RPL4 DDX39B XRCC6 NOL8 FTSJ3 | 5.71e-08 | 1294 | 140 | 21 | 30804502 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | EPRS1 RPS11 EXOSC1 HMGB1 HAUS3 CHD4 VPS16 NDUFC2 ACTR3 HMGB1P1 EEF1B2 IGF2BP3 EIF3B TALDO1 RPL4 DDX39B XRCC6 | 6.06e-08 | 847 | 140 | 17 | 35235311 |
| Pubmed | IMPDH2 ATRX DNAH10 RBBP6 RC3H1 RPS11 HMGB1 EWSR1 SSB ACTR3 IGF2BP3 FAT1 DDX50 MRPL38 ASXL2 EIF3B HCFC2 HERC2 HERC1 XRCC6 PACSIN2 FTSJ3 | 6.69e-08 | 1429 | 140 | 22 | 35140242 | |
| Pubmed | EPRS1 RBBP6 PARK7 RPS11 EWSR1 CHD4 SSB TUFM ZNF800 DDX50 SGPL1 RPL4 HSPB8 XRCC6 FTSJ3 | 7.09e-08 | 655 | 140 | 15 | 35819319 | |
| Pubmed | IMPDH2 ACAD9 UGGT1 EXOSC1 HMGB1 CHD4 SSB XPO1 HNRNPAB PAICS ACTR3 TUFM EEF1B2 IGF2BP3 DDX50 FANCI SGPL1 AHNAK SUPT16H EIF3B HCFC2 XRCC6 | 7.64e-08 | 1440 | 140 | 22 | 30833792 | |
| Pubmed | EPRS1 IMPDH2 RPS11 HMGB1 SSB PAICS TUFM IGF2BP3 AHNAK SUPT16H TALDO1 DDX39B | 8.14e-08 | 397 | 140 | 12 | 21319273 | |
| Pubmed | EPRS1 IMPDH2 ACAT1 RPS11 XPO1 HNRNPAB PAICS TUFM EEF1B2 IGF2BP3 EIF3B PALS2 RPL4 | 9.03e-08 | 484 | 140 | 13 | 31995728 | |
| Pubmed | EIF3H Orchestrates Hippo Pathway-Mediated Oncogenesis via Catalytic Control of YAP Stability. | 9.41e-08 | 55 | 140 | 6 | 32269044 | |
| Pubmed | Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation. | 1.04e-07 | 258 | 140 | 10 | 21081666 | |
| Pubmed | EPRS1 ACAT1 RPS11 HMGB1 EWSR1 CHD4 XPO1 HNRNPAB EEF1B2 EIF3B RPL4 DDX39B XRCC6 | 1.07e-07 | 491 | 140 | 13 | 22623428 | |
| Pubmed | ATRX EXOSC1 EWSR1 CHD4 XPO1 ACTR3 TUFM DDX50 RPL4 DDX39B XRCC6 FTSJ3 | 1.45e-07 | 419 | 140 | 12 | 15635413 | |
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | IMPDH2 UGGT1 EWSR1 CHD4 SSB XPO1 BIRC6 ACTR3 SUPT16H EIF3B RPL4 | 1.65e-07 | 344 | 140 | 11 | 30333137 |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | IMPDH2 ACAT1 RBBP6 EXOSC1 EWSR1 HNRNPAB PAICS TUFM POLR1F SGPL1 SUPT16H EIF3B DDX39B XRCC6 FTSJ3 | 1.70e-07 | 701 | 140 | 15 | 30196744 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | RBBP6 RC3H1 HMGB1 EWSR1 SSB HNRNPAB IGF2BP3 DDX50 SUPT16H PWP2 RPL4 DDX39B XRCC6 PUS7 NOL8 FTSJ3 | 1.80e-07 | 807 | 140 | 16 | 22681889 |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | IMPDH2 ACAT1 RPS11 HMGB1 EWSR1 SSB XPO1 LCN1 PAICS HMGB1P1 IGF2BP3 SUPT16H EIF3B TALDO1 | 1.82e-07 | 607 | 140 | 14 | 39147351 |
| Pubmed | EPRS1 ACAT1 RBBP6 RC3H1 UGGT1 EWSR1 HNRNPAB IGF2BP3 RPL4 DDX39B | 1.82e-07 | 274 | 140 | 10 | 34244482 | |
| Pubmed | EPRS1 IMPDH2 ACAT1 RPS11 EWSR1 CHD4 SSB HNRNPAB PAICS TUFM EEF1B2 IGF2BP3 AHNAK EIF3B RPL4 XRCC6 | 1.86e-07 | 809 | 140 | 16 | 32129710 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | ATRX CHD4 ACTR3 EEF1B2 IGF2BP3 DDX50 SUPT16H PWP2 XRCC6 NOL8 FTSJ3 | 1.90e-07 | 349 | 140 | 11 | 25665578 |
| Pubmed | SORBS2 WFS1 VPS13C SPTA1 VPS16 PAICS ACTR3 MAGI2 ELFN1 SGPL1 HERC2 CAMSAP2 | 1.92e-07 | 430 | 140 | 12 | 32581705 | |
| Pubmed | 2.15e-07 | 63 | 140 | 6 | 37052853 | ||
| Pubmed | EPRS1 ABCA2 IMPDH2 WWP2 RPS11 PDCD2L CHD4 XPO1 ITGAX BIRC6 PAICS ACTR3 TUFM DDX50 FANCI AHNAK HERC2 RPL4 XRCC6 | 2.51e-07 | 1168 | 140 | 19 | 19946888 | |
| Pubmed | 2.57e-07 | 106 | 140 | 7 | 19394292 | ||
| Pubmed | PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation. | 2.62e-07 | 217 | 140 | 9 | 31685992 | |
| Pubmed | MBD5 and MBD6 stabilize the BAP1 complex and promote BAP1-dependent cancer. | IMPDH2 PARK7 APOA2 PDCD2L PAICS ACTR3 TUFM EEF1B2 ASXL2 XRCC6 | 2.80e-07 | 287 | 140 | 10 | 36180891 |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 2.94e-07 | 220 | 140 | 9 | 35785414 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | EPRS1 RBBP6 RPS11 EWSR1 CHD4 HNRNPAB ACTR3 TUFM IGF2BP3 DDX50 AHNAK SUPT16H EIF3B RPL4 DDX39B XRCC6 FTSJ3 | 3.01e-07 | 949 | 140 | 17 | 36574265 |
| Pubmed | 3.30e-07 | 223 | 140 | 9 | 20020773 | ||
| Pubmed | Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy. | IMPDH2 RPS11 EXOSC1 VPS16 XPO1 TUFM POLR1F PWP2 PITPNB RPL4 XRCC6 FTSJ3 | 3.42e-07 | 454 | 140 | 12 | 33226137 |
| Pubmed | FAF1 phosphorylation by AKT accumulates TGF-β type II receptor and drives breast cancer metastasis. | 3.43e-07 | 224 | 140 | 9 | 28443643 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SORBS2 IMPDH2 RBBP6 HMGB1 EWSR1 CHD4 XPO1 HNRNPAB TUFM IGF2BP3 DDX50 SCG3 SUPT16H EIF3B RPL4 TNXB DDX39B XRCC6 | 3.87e-07 | 1082 | 140 | 18 | 38697112 |
| Pubmed | EPRS1 ACAT1 PARK7 HMGB1 EWSR1 HNRNPAB PAICS ACTR3 TUFM SAG TALDO1 DDX39B PACSIN2 | 4.04e-07 | 552 | 140 | 13 | 36293380 | |
| Pubmed | RBBP6 ACAD9 HMGB1 EWSR1 SSB XPO1 TUFM EEF1B2 DDX50 NUB1 EIF3B PALS2 XRCC6 PUS7 | 4.37e-07 | 653 | 140 | 14 | 33742100 | |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | EPRS1 IMPDH2 ACAT1 RPS11 SSB LCN1 HNRNPAB TUFM EEF1B2 AHNAK EIF3B RPL4 DDX39B | 4.56e-07 | 558 | 140 | 13 | 27591049 |
| Pubmed | 4.73e-07 | 304 | 140 | 10 | 32235678 | ||
| Pubmed | EPRS1 IMPDH2 RPS11 SSB XPO1 TUFM EEF1B2 IGF2BP3 HERC2 RPL4 XRCC6 | 4.78e-07 | 383 | 140 | 11 | 29331416 | |
| Pubmed | RPS11 ACTR3 TUFM FAM83H NTNG2 AHNAK GAPDHS RPL4 DDX39B XRCC6 | 4.88e-07 | 305 | 140 | 10 | 33194618 | |
| Pubmed | 6.48e-07 | 177 | 140 | 8 | 26206133 | ||
| Pubmed | EPRS1 ERCC5 HMGB1 CHD4 SSB XPO1 PAICS ACTR3 POLR1F AHNAK XRCC6 | 7.14e-07 | 399 | 140 | 11 | 37536630 | |
| Pubmed | EPRS1 IMPDH2 ACAT1 PARK7 HMGB1 CHD4 SSB HNRNPAB PAICS EEF1B2 SUPT16H PITPNB EIF3B DDX39B XRCC6 | 7.18e-07 | 786 | 140 | 15 | 29128334 | |
| Pubmed | 7.25e-07 | 245 | 140 | 9 | 21182205 | ||
| Pubmed | Enhancer Activity Requires CBP/P300 Bromodomain-Dependent Histone H3K27 Acetylation. | 7.35e-07 | 180 | 140 | 8 | 30110629 | |
| Pubmed | EPRS1 SORBS2 KIAA0513 ACAT1 WFS1 PARK7 HMGCL GRIN2B BIRC6 HNRNPAB RYR2 MAGI2 EEF1B2 SHANK2 ELFN1 EIF3B CAMSAP2 DDX39B | 8.10e-07 | 1139 | 140 | 18 | 36417873 | |
| Pubmed | SASH1 ATRX RBBP6 WWP2 EWSR1 RYR2 PTPN12 PITPNB ASXL2 HERC2 HERC1 TNKS2 XRCC6 | 8.67e-07 | 591 | 140 | 13 | 15231748 | |
| Pubmed | 9.46e-07 | 253 | 140 | 9 | 29911972 | ||
| Pubmed | 9.97e-07 | 330 | 140 | 10 | 32529326 | ||
| Pubmed | Tissue-Specific Regulation of the Wnt/β-Catenin Pathway by PAGE4 Inhibition of Tankyrase. | 1.04e-06 | 256 | 140 | 9 | 32698014 | |
| Pubmed | EPRS1 ACAT1 ACAD9 RPS11 CHD4 VPS16 TUFM EEF1B2 IGF2BP3 SGPL1 AHNAK SUPT16H RPL4 | 1.04e-06 | 601 | 140 | 13 | 33658012 | |
| Pubmed | Lysosomal Signaling Licenses Embryonic Stem Cell Differentiation via Inactivation of Tfe3. | PARK7 RPS11 HMGB1 SALL4 EWSR1 CHD4 HNRNPAB EEF1B2 RPL4 XRCC6 | 1.05e-06 | 332 | 140 | 10 | 30595499 |
| Pubmed | Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion. | IMPDH2 EWSR1 PDCD2L SSB XPO1 HNRNPAB ACTR3 TUFM IGF2BP3 PALS2 RPL4 DDX39B XRCC6 FTSJ3 | 1.06e-06 | 704 | 140 | 14 | 32994395 |
| Pubmed | EPRS1 UGGT1 RPS11 XPO1 LCN1 ACTR3 TUFM AHNAK SUPT16H HERC2 RPL4 | 1.12e-06 | 418 | 140 | 11 | 35338135 | |
| Pubmed | 1.15e-06 | 259 | 140 | 9 | 31162944 | ||
| Pubmed | 1.19e-06 | 260 | 140 | 9 | 36199071 | ||
| Pubmed | ABCA2 SH2D3C SSB TUFM EEF1B2 IGF2BP3 DDX50 CNGB3 TNFAIP2 HERC2 XRCC6 DSE | 1.23e-06 | 513 | 140 | 12 | 25798074 | |
| Pubmed | EPRS1 RPS11 SSB HNRNPAB TUFM IGF2BP3 DDX50 SUPT16H MRPL38 RPL4 FTSJ3 | 1.32e-06 | 425 | 140 | 11 | 21081503 | |
| Interaction | RBM39 interactions | EPRS1 IMPDH2 ATRX ACAT1 RC3H1 WWP2 RPS11 HMGB1 CHD4 SSB XPO1 HNRNPAB PAICS ACTR3 TUFM EEF1B2 IGF2BP3 DDX50 SGPL1 SUPT16H EIF3B GAPDHS HERC2 TALDO1 RPL4 DDX39B XRCC6 | 1.62e-09 | 1042 | 137 | 27 | int:RBM39 |
| Interaction | BAP1 interactions | EPRS1 IMPDH2 PARK7 UGGT1 RPS11 DNAJB4 HMGB1 EWSR1 CHD4 SSB XPO1 HNRNPAB PAICS ACTR3 TUFM EEF1B2 IGF2BP3 FAT1 FANCI AHNAK SUPT16H ASXL2 EIF3B HCFC2 TALDO1 RPL4 DDX39B XRCC6 PACSIN2 FTSJ3 | 3.34e-09 | 1314 | 137 | 30 | int:BAP1 |
| Interaction | NPM1 interactions | EPRS1 DPY19L3 IMPDH2 PARK7 RC3H1 WWP2 RPS11 DNAJB4 HMGB1 EWSR1 CHD4 SSB XPO1 PAICS TUFM EEF1B2 ZNF800 IGF2BP3 PTPN12 DDX50 SGPL1 SUPT16H MRPL38 ASXL2 RP1 RPL4 XRCC6 FTSJ3 | 7.87e-09 | 1201 | 137 | 28 | int:NPM1 |
| Interaction | RPS25 interactions | VPS13C RC3H1 WWP2 RPS11 EXOSC1 DNAJB4 HMGB1 EWSR1 CHD4 SSB XPO1 ASXL2 EIF3B DNAJB5 RPL4 DDX39B | 1.08e-08 | 392 | 137 | 16 | int:RPS25 |
| Interaction | CHMP4B interactions | EPRS1 SORBS2 IMPDH2 ATRX PARK7 UGGT1 RPS11 PAICS ACTR3 TUFM FAM83H DDX50 FANCI AHNAK SUPT16H PWP2 GNAL HERC2 PALS2 RPL4 XRCC6 | 2.13e-08 | 727 | 137 | 21 | int:CHMP4B |
| Interaction | MEN1 interactions | EPRS1 PHF20 IMPDH2 ATRX UBE4B RBBP6 RPS11 EXOSC1 EWSR1 CHD4 SSB XPO1 GRHL2 HNRNPAB PAICS IGF2BP3 DDX50 FANCI SGPL1 SUPT16H PWP2 HCFC2 RPL4 NOL8 FTSJ3 | 2.57e-08 | 1029 | 137 | 25 | int:MEN1 |
| Interaction | RPL31 interactions | ERCC5 RC3H1 WWP2 RPS11 HMGB1 EWSR1 CHD4 SSB HNRNPAB TUFM EEF1B2 IGF2BP3 DDX50 FANCI SUPT16H EIF3B RPL4 XRCC6 NOL8 FTSJ3 | 3.56e-08 | 680 | 137 | 20 | int:RPL31 |
| Interaction | KIF20A interactions | ANKRD35 IMPDH2 RBBP6 RPS11 CHD4 XPO1 HNRNPAB RGS12 TUFM FAM83H IGF2BP3 DDX50 ELFN1 FANCI AHNAK SUPT16H PWP2 GNAL HERC2 HERC1 RPL4 DDX39B HSPB8 XRCC6 FTSJ3 | 3.95e-08 | 1052 | 137 | 25 | int:KIF20A |
| Interaction | BIRC3 interactions | EPRS1 IMPDH2 DNAH10 ACAT1 ACAD9 PARK7 UGGT1 RPS11 HMGB1 HMGCL CHD4 SSB XPO1 HNRNPAB PAICS ACTR3 TUFM EEF1B2 DDX50 FANCI SUPT16H PWP2 EIF3B TALDO1 RPL4 DDX39B XRCC6 FTSJ3 | 7.39e-08 | 1334 | 137 | 28 | int:BIRC3 |
| Interaction | U2AF2 interactions | EPRS1 IMPDH2 PARK7 RC3H1 WWP2 HMGB1 EWSR1 CHD4 SSB HNRNPAB PAICS TUFM SCG3 AHNAK HERC2 TALDO1 DDX39B XRCC6 FTSJ3 | 9.13e-08 | 651 | 137 | 19 | int:U2AF2 |
| Interaction | CIT interactions | ANKRD35 SORBS2 IMPDH2 ACAT1 RBBP6 RPS11 CHD4 SSB GRIN2B XPO1 BIRC6 HNRNPAB ACTR3 TUFM EEF1B2 IGF2BP3 DDX50 ELFN1 FANCI AHNAK SUPT16H PWP2 EIF3B GAPDHS HERC1 RPL4 DDX39B XRCC6 FTSJ3 | 1.16e-07 | 1450 | 137 | 29 | int:CIT |
| Interaction | RPS24 interactions | RC3H1 WWP2 RPS11 HMGB1 CHD4 CCDC168 SSB TUFM EEF1B2 DDX50 FANCI PWP2 EIF3B HERC2 RPL4 NOL8 FTSJ3 | 1.19e-07 | 529 | 137 | 17 | int:RPS24 |
| Interaction | SIRT7 interactions | IMPDH2 ACAT1 UGGT1 EWSR1 CHD4 SSB XPO1 BIRC6 PAICS ACTR3 TUFM UBE2R2 IGF2BP3 FANCI AHNAK PWP2 HERC2 RPL4 XRCC6 FTSJ3 | 1.53e-07 | 744 | 137 | 20 | int:SIRT7 |
| Interaction | RPS4X interactions | EPRS1 RC3H1 WWP2 UGGT1 RPS11 EXOSC1 HMGB1 CHD4 SSB XPO1 HNRNPAB EEF1B2 IGF2BP3 EIF3B RPL4 DDX39B XRCC6 | 1.59e-07 | 540 | 137 | 17 | int:RPS4X |
| Interaction | LRRC31 interactions | EPRS1 IMPDH2 UGGT1 SALL4 XPO1 TUFM AHNAK SUPT16H HERC2 RPL4 XRCC6 | 1.60e-07 | 205 | 137 | 11 | int:LRRC31 |
| Interaction | CHMP4C interactions | EPRS1 RPS11 HMGB1 XPO1 HNRNPAB ACTR3 TUFM FAM83H EEF1B2 IGF2BP3 DDX50 AHNAK SUPT16H PWP2 EIF3B GAPDHS RPL4 XRCC6 FTSJ3 | 2.10e-07 | 687 | 137 | 19 | int:CHMP4C |
| Interaction | NR2C2 interactions | EPRS1 IMPDH2 ACAT1 RBBP6 RPS11 HMGB1 EWSR1 CHD4 SSB HNRNPAB PAICS ACTR3 TUFM FAM83H POLR1F EEF1B2 IGF2BP3 DDX50 AHNAK SUPT16H PWP2 EIF3B MORC3 TALDO1 RPL4 DDX39B XRCC6 FTSJ3 | 2.10e-07 | 1403 | 137 | 28 | int:NR2C2 |
| Interaction | HSD17B10 interactions | ACAT1 ACAD9 PARK7 RC3H1 WWP2 HMGCL SSB BIRC6 HNRNPAB ACTR3 TUFM EEF1B2 PITPNB ASXL2 XRCC6 | 2.76e-07 | 434 | 137 | 15 | int:HSD17B10 |
| Interaction | BRCA1 interactions | EPRS1 ERCC5 IMPDH2 PARK7 UGGT1 RPS11 EWSR1 SSB XPO1 HNRNPAB PAICS FAM83H EEF1B2 IGF2BP3 FANCI AHNAK SUPT16H EIF3B MORC3 HERC2 HERC1 TNKS2 TALDO1 RPL4 DDX39B XRCC6 | 2.76e-07 | 1249 | 137 | 26 | int:BRCA1 |
| Interaction | AGR2 interactions | EPRS1 ABCA2 IMPDH2 ACAT1 PARK7 SPTA1 UGGT1 RPS11 HMGB1 EWSR1 CHD4 CLSTN2 PAICS ACTR3 TUFM EEF1B2 AHNAK EIF3B PALS2 TALDO1 RPL4 XRCC6 | 3.36e-07 | 934 | 137 | 22 | int:AGR2 |
| Interaction | EED interactions | EPRS1 IMPDH2 UBE4B RBBP6 VPS13C UGGT1 RPS11 SALL4 CHD4 SSB VPS16 XPO1 BIRC6 HNRNPAB ACTR3 TUFM EEF1B2 DDX50 SGPL1 SUPT16H PWP2 EIF3B MORC3 HERC2 RPL4 DDX39B XRCC6 FTSJ3 | 3.83e-07 | 1445 | 137 | 28 | int:EED |
| Interaction | EFTUD2 interactions | EPRS1 ERCC5 IMPDH2 PARK7 RC3H1 WWP2 UGGT1 RPS11 DNAJB4 HMGB1 EWSR1 CHD4 SSB BIRC6 HNRNPAB PAICS TUFM EEF1B2 IGF2BP3 AHNAK SUPT16H ASXL2 EIF3B RPL4 DDX39B XRCC6 PUS7 FTSJ3 | 4.05e-07 | 1449 | 137 | 28 | int:EFTUD2 |
| Interaction | RPS6 interactions | IMPDH2 RC3H1 WWP2 UGGT1 RPS11 HMGB1 CHD4 SSB XPO1 TUFM IGF2BP3 DDX50 FANCI SCG3 SUPT16H PWP2 EIF3B RPL4 XRCC6 NOL8 FTSJ3 | 4.65e-07 | 874 | 137 | 21 | int:RPS6 |
| Interaction | SNU13 interactions | EPRS1 IMPDH2 RC3H1 WWP2 RPS11 CHD4 SSB SUPT16H ASXL2 RPL4 XRCC6 PUS7 | 5.87e-07 | 285 | 137 | 12 | int:SNU13 |
| Interaction | PCBP1 interactions | EPRS1 IMPDH2 RBBP6 RC3H1 WWP2 EWSR1 PAICS TUFM IGF2BP3 AHNAK PITPNB ASXL2 HERC2 CAMSAP2 TALDO1 RPL4 DDX39B XRCC6 | 7.02e-07 | 671 | 137 | 18 | int:PCBP1 |
| Interaction | PTEN interactions | EPRS1 ATRX ACAT1 RBBP6 PARK7 WWP2 SPTA1 UGGT1 RPS11 EXOSC1 CHD4 SSB BIRC6 HNRNPAB TUFM TMEFF1 MAGI2 DDX50 PITPNB TNKS2 XRCC6 | 1.24e-06 | 929 | 137 | 21 | int:PTEN |
| Interaction | WDR5 interactions | EPRS1 PHF20 IMPDH2 ACAT1 WWP2 RPS11 HMGB1 SALL4 EWSR1 CHD4 SSB XPO1 HNRNPAB TUFM EEF1B2 IGF2BP3 SUPT16H ASXL2 EIF3B HCFC2 RPL4 DDX39B XRCC6 | 1.41e-06 | 1101 | 137 | 23 | int:WDR5 |
| Interaction | RPS10 interactions | RC3H1 WWP2 RPS11 HMGB1 EWSR1 CHD4 SSB XPO1 HNRNPAB ZNF800 IGF2BP3 DDX50 ASXL2 EIF3B RPL4 XRCC6 | 1.59e-06 | 567 | 137 | 16 | int:RPS10 |
| Interaction | RPS11 interactions | ANKRD35 RC3H1 WWP2 UGGT1 RPS11 HMGB1 CHD4 SSB VPS16 XPO1 TUFM EEF1B2 IGF2BP3 EIF3B RPL4 | 1.84e-06 | 505 | 137 | 15 | int:RPS11 |
| Interaction | CSNK2A1 interactions | ERCC5 ATRX WWP2 RPS11 HMGB1 CHD4 SSB GRIN2B XPO1 BIRC6 EEF1B2 UBE2R2 SNCAIP SUPT16H MRPL38 ASXL2 EIF3B RPL4 HSPB8 XRCC6 FTSJ3 | 1.96e-06 | 956 | 137 | 21 | int:CSNK2A1 |
| Interaction | RPS8 interactions | EPRS1 RC3H1 WWP2 RPS11 HMGB1 CHD4 SSB XPO1 HNRNPAB TUFM EEF1B2 IGF2BP3 DDX50 MRPL38 EIF3B RPL4 FTSJ3 | 2.03e-06 | 649 | 137 | 17 | int:RPS8 |
| Interaction | KCTD13 interactions | EPRS1 SORBS2 ACAT1 WFS1 PARK7 SPTA1 RPS11 HMGB1 NCAM2 EWSR1 SSB GRIN2B XPO1 HNRNPAB NDUFC2 ACTR3 TUFM MAGI2 EEF1B2 SHANK2 SGPL1 PRKAG2 CAMSAP2 RPL4 DDX39B HSPB8 | 2.19e-06 | 1394 | 137 | 26 | int:KCTD13 |
| Interaction | RPS20 interactions | IMPDH2 RC3H1 WWP2 RPS11 EXOSC1 HMGB1 CHD4 SSB TUFM EEF1B2 IGF2BP3 EIF3B GAPDHS PALS2 RPL4 | 2.24e-06 | 513 | 137 | 15 | int:RPS20 |
| Interaction | DOT1L interactions | EPRS1 ATRX RBBP6 RPS11 EXOSC1 CHD4 SSB XPO1 HNRNPAB PAICS EEF1B2 IGF2BP3 DDX50 SGPL1 PWP2 EIF3B HCFC2 NOL8 FTSJ3 | 2.34e-06 | 807 | 137 | 19 | int:DOT1L |
| Interaction | H1-4 interactions | EPRS1 WFS1 RC3H1 HMGB1 CHD4 SSB HNRNPAB NME8 TUFM IGF2BP3 PTPN12 DDX50 ASXL2 GAPDHS RPL4 CFAP46 FTSJ3 | 2.34e-06 | 656 | 137 | 17 | int:H1-4 |
| Interaction | PRC1 interactions | ANKRD35 ATRX UBE4B RBBP6 WWP2 RPS11 CHD4 HNRNPAB RGS12 TUFM FAM83H IGF2BP3 DDX50 AHNAK SUPT16H PWP2 GAPDHS HERC1 RPL4 XRCC6 FTSJ3 | 2.59e-06 | 973 | 137 | 21 | int:PRC1 |
| Interaction | SUMO2 interactions | ANKRD35 EPRS1 IMPDH2 ATRX PARK7 EWSR1 CHD4 XPO1 HMGB1P1 AHNAK SUPT16H MORC3 ZBED1 RPL4 DDX39B XRCC6 | 2.72e-06 | 591 | 137 | 16 | int:SUMO2 |
| Interaction | RPSA interactions | RC3H1 WWP2 SPTA1 RPS11 HMGB1 EWSR1 CHD4 SSB XPO1 EEF1B2 IGF2BP3 EIF3B RPL4 XRCC6 FTSJ3 | 2.77e-06 | 522 | 137 | 15 | int:RPSA |
| Interaction | NAA40 interactions | EPRS1 IMPDH2 ATRX RBBP6 PARK7 RPS11 PDCD2L CHD4 HNRNPAB EEF1B2 IGF2BP3 PTPN12 DDX50 AHNAK SUPT16H CAMSAP2 RPL4 XRCC6 PUS7 NOL8 FTSJ3 | 2.80e-06 | 978 | 137 | 21 | int:NAA40 |
| Interaction | RPS7 interactions | ATRX VPS13C RC3H1 WWP2 RPS11 CHD4 SSB XPO1 EEF1B2 IGF2BP3 ASXL2 EIF3B RPL4 DDX39B | 3.64e-06 | 466 | 137 | 14 | int:RPS7 |
| Interaction | EIF3H interactions | SORBS2 WWP2 RPS11 SSB XPO1 ACTR3 TUFM EIF3B HERC2 RPL4 XRCC6 | 3.69e-06 | 282 | 137 | 11 | int:EIF3H |
| Interaction | RPL7A interactions | EPRS1 ATRX RC3H1 WWP2 UGGT1 RPS11 HMGB1 EWSR1 CHD4 SSB XPO1 EEF1B2 IGF2BP3 DDX50 HERC2 RPL4 FTSJ3 | 3.71e-06 | 679 | 137 | 17 | int:RPL7A |
| Interaction | RPL23A interactions | EPRS1 RC3H1 WWP2 RPS11 HMGB1 CHD4 SSB XPO1 TUFM ZNF800 IGF2BP3 AHNAK EIF3B RPL4 TNXB FTSJ3 | 3.75e-06 | 606 | 137 | 16 | int:RPL23A |
| Interaction | RPS15A interactions | RC3H1 WWP2 RPS11 EXOSC1 HMGB1 EWSR1 CHD4 SSB TUFM EEF1B2 EIF3B RPL4 DDX39B | 3.83e-06 | 403 | 137 | 13 | int:RPS15A |
| Interaction | CHD3 interactions | EPRS1 RPS11 SALL4 EWSR1 CHD4 LCN1 HNRNPAB PAICS IGF2BP3 DDX50 SUPT16H PWP2 EIF3B ZBED1 RPL4 DDX39B XRCC6 FTSJ3 | 3.86e-06 | 757 | 137 | 18 | int:CHD3 |
| Interaction | TFE3 interactions | EPRS1 PARK7 RPS11 HMGB1 SALL4 EWSR1 CHD4 XPO1 HNRNPAB EEF1B2 RPL4 XRCC6 | 4.16e-06 | 344 | 137 | 12 | int:TFE3 |
| Interaction | STIP1 interactions | EPRS1 RPS11 DNAJB4 EWSR1 CHD4 SSB XPO1 HNRNPAB PAICS TUFM FAM83H FANCI AHNAK SUPT16H PWP2 WRAP73 EIF3B DNAJB5 RPL4 DDX39B XRCC6 | 4.35e-06 | 1006 | 137 | 21 | int:STIP1 |
| Interaction | FN1 interactions | EPRS1 IMPDH2 RPS11 HMGB1 EWSR1 SSB XPO1 HNRNPAB PAICS ACTR3 TUFM EEF1B2 IGF2BP3 AHNAK C1S EIF3B RPL4 DDX39B XRCC6 | 4.80e-06 | 848 | 137 | 19 | int:FN1 |
| Interaction | TFCP2L1 interactions | 5.09e-06 | 99 | 137 | 7 | int:TFCP2L1 | |
| Interaction | RPS18 interactions | RC3H1 WWP2 RPS11 HMGB1 CHD4 SSB XPO1 EEF1B2 IGF2BP3 ASXL2 EIF3B RPL4 XRCC6 | 5.27e-06 | 415 | 137 | 13 | int:RPS18 |
| Interaction | CHD4 interactions | EPRS1 RBBP6 PARK7 RPS11 NCAM2 SALL4 EWSR1 CHD4 LCN1 BIRC6 HNRNPAB DDX50 AHNAK SUPT16H PWP2 EIF3B RPL4 DDX39B XRCC6 FTSJ3 | 5.52e-06 | 938 | 137 | 20 | int:CHD4 |
| Interaction | METTL14 interactions | TDRD5 UGGT1 RPS11 EWSR1 SSB HNRNPAB ACTR3 TUFM HMGB1P1 AHNAK GNAL HERC1 RPL4 DDX39B XRCC6 | 6.20e-06 | 558 | 137 | 15 | int:METTL14 |
| Interaction | UFL1 interactions | EPRS1 IMPDH2 ACAT1 RPS11 HMGB1 EWSR1 SSB XPO1 HNRNPAB PAICS TUFM EEF1B2 IGF2BP3 DDX50 SUPT16H PWP2 EIF3B SAYSD1 RPL4 XRCC6 FTSJ3 | 6.35e-06 | 1031 | 137 | 21 | int:UFL1 |
| Interaction | RPL10A interactions | RC3H1 WWP2 RPS11 HMGB1 CHD4 SSB XPO1 ZNF800 IGF2BP3 DDX50 EIF3B RPL4 NOL8 FTSJ3 | 6.47e-06 | 490 | 137 | 14 | int:RPL10A |
| Interaction | HTT interactions | EPRS1 PHF20 SASH1 WFS1 SPTA1 HMGB1 HAUS3 SSB GRIN2B ACTR3 EEF1B2 NUB1 EIF3B GNAL GAPDHS MORC3 RPL4 HSPB8 XRCC6 PACSIN2 | 6.56e-06 | 949 | 137 | 20 | int:HTT |
| Interaction | OGT interactions | RNASEH2B IMPDH2 RC3H1 WWP2 EWSR1 PDCD2L SSB XPO1 HNRNPAB ACTR3 TUFM IGF2BP3 WRAP73 ASXL2 HCFC2 PALS2 RPL4 DDX39B XRCC6 FTSJ3 | 6.66e-06 | 950 | 137 | 20 | int:OGT |
| Interaction | EIF2S3 interactions | IMPDH2 ATRX UGGT1 RPS11 XPO1 IGF2BP3 FANCI EIF3B RPL4 DDX39B XRCC6 | 7.78e-06 | 305 | 137 | 11 | int:EIF2S3 |
| Interaction | RPS3 interactions | EPRS1 RC3H1 WWP2 RPS11 HMGB1 CHD4 SSB XPO1 HNRNPAB TUFM EEF1B2 IGF2BP3 PWP2 ASXL2 EIF3B RPL4 DDX39B | 8.19e-06 | 721 | 137 | 17 | int:RPS3 |
| Interaction | MRPS18B interactions | ACAD9 PSKH1 PARK7 RC3H1 HMGB1 EWSR1 HNRNPAB TUFM IGF2BP3 GAPDHS EPHA8 | 8.27e-06 | 307 | 137 | 11 | int:MRPS18B |
| Interaction | RPS16 interactions | EPRS1 RC3H1 WWP2 RPS11 EXOSC1 HMGB1 CHD4 SSB XPO1 TUFM IGF2BP3 DDX50 SGPL1 ASXL2 EIF3B RPL4 FTSJ3 | 8.64e-06 | 724 | 137 | 17 | int:RPS16 |
| Interaction | RPS3A interactions | EPRS1 RC3H1 WWP2 RPS11 HMGB1 CHD4 SSB XPO1 HNRNPAB PAICS EEF1B2 IGF2BP3 EIF3B RPL4 DDX39B FTSJ3 | 9.96e-06 | 655 | 137 | 16 | int:RPS3A |
| Interaction | RPS2 interactions | RC3H1 WWP2 UGGT1 RPS11 HMGB1 PDCD2L CHD4 SSB XPO1 TUFM EEF1B2 IGF2BP3 EIF3B SAYSD1 RPL4 DDX39B | 1.03e-05 | 657 | 137 | 16 | int:RPS2 |
| Interaction | PABPC4 interactions | EPRS1 RC3H1 WWP2 RPS11 CHD4 SSB XPO1 HNRNPAB IGF2BP3 EIF3B HERC2 RPL4 DDX39B | 1.04e-05 | 442 | 137 | 13 | int:PABPC4 |
| Interaction | RPS9 interactions | EPRS1 WWP2 RPS11 HMGB1 CHD4 XPO1 HNRNPAB EEF1B2 IGF2BP3 DDX50 EIF3B HERC2 RPL4 FTSJ3 | 1.14e-05 | 515 | 137 | 14 | int:RPS9 |
| Interaction | DDRGK1 interactions | EPRS1 DPY19L3 ACAT1 PARK7 RPS11 EXOSC1 HMGB1 EWSR1 SSB XPO1 HNRNPAB PAICS TUFM EEF1B2 IGF2BP3 DDX50 SGPL1 SUPT16H PWP2 RPL4 XRCC6 EPHA8 FTSJ3 | 1.14e-05 | 1249 | 137 | 23 | int:DDRGK1 |
| Interaction | LGALS9 interactions | EPRS1 ABCA2 IMPDH2 ACAT1 RPS11 XPO1 HNRNPAB PAICS TUFM EEF1B2 IGF2BP3 SGPL1 EIF3B PALS2 RPL4 | 1.16e-05 | 588 | 137 | 15 | int:LGALS9 |
| Interaction | ATG16L1 interactions | IMPDH2 ACAT1 RBBP6 VPS13C EXOSC1 EWSR1 CCDC168 XPO1 HNRNPAB PAICS TUFM RYR2 POLR1F ELFN1 SGPL1 SUPT16H EIF3B HERC1 TNKS2 DDX39B XRCC6 FTSJ3 | 1.17e-05 | 1161 | 137 | 22 | int:ATG16L1 |
| Interaction | TGS1 interactions | 1.21e-05 | 75 | 137 | 6 | int:TGS1 | |
| Interaction | RPL13A interactions | EPRS1 RC3H1 WWP2 UGGT1 RPS11 HMGB1 SSB HNRNPAB RYR2 EEF1B2 DDX50 PWP2 RPL4 NOL8 FTSJ3 | 1.23e-05 | 591 | 137 | 15 | int:RPL13A |
| Interaction | CCDC124 interactions | 1.29e-05 | 114 | 137 | 7 | int:CCDC124 | |
| Interaction | SMC5 interactions | EPRS1 ATRX ACAT1 RBBP6 HMGB1 EWSR1 CHD4 HNRNPAB HMGB1P1 POLR1F EEF1B2 DDX50 FANCI AHNAK SUPT16H PWP2 DDX39B XRCC6 NOL8 FTSJ3 | 1.41e-05 | 1000 | 137 | 20 | int:SMC5 |
| Interaction | RPL27A interactions | RC3H1 WWP2 RPS11 EXOSC1 HMGB1 CHD4 SSB EEF1B2 MRPL38 EIF3B RPL4 XRCC6 FTSJ3 | 1.54e-05 | 459 | 137 | 13 | int:RPL27A |
| Interaction | PINK1 interactions | EPRS1 IMPDH2 UBE4B PARK7 CHD4 SSB LCN1 PAICS TUFM IGF2BP3 SNCAIP AHNAK SUPT16H EIF3B DDX39B XRCC6 | 1.55e-05 | 679 | 137 | 16 | int:PINK1 |
| Interaction | ACE2 interactions | EPRS1 IMPDH2 ACAT1 PARK7 RPS11 EWSR1 XPO1 HNRNPAB PAICS ACTR3 TUFM EEF1B2 IGF2BP3 SHANK2 SUPT16H EIF3B GAPDHS RPL4 DDX39B XRCC6 PACSIN2 | 1.83e-05 | 1106 | 137 | 21 | int:ACE2 |
| Interaction | MECP2 interactions | SORBS2 IMPDH2 ATRX RBBP6 RPS11 HMGB1 EWSR1 CHD4 XPO1 HNRNPAB TUFM ZNF800 IGF2BP3 DDX50 SCG3 SUPT16H PWP2 EIF3B RPL4 TNXB DDX39B XRCC6 NOL8 | 1.84e-05 | 1287 | 137 | 23 | int:MECP2 |
| Interaction | RPL8 interactions | RC3H1 WWP2 UGGT1 RPS11 HMGB1 EWSR1 CHD4 XPO1 TUFM EEF1B2 IGF2BP3 DDX50 RPL4 FTSJ3 | 1.89e-05 | 539 | 137 | 14 | int:RPL8 |
| Interaction | CUL4A interactions | EPRS1 SPTA1 UGGT1 RPS11 EWSR1 HMGCL CHD4 XPO1 LCN1 HNRNPAB PAICS RGS12 SUPT16H NUB1 GAPDHS RPL4 DDX39B XRCC6 | 1.98e-05 | 854 | 137 | 18 | int:CUL4A |
| Interaction | RPTOR interactions | UBE4B XPO1 PAICS TUFM HMGB1P1 EEF1B2 EIF3B RPL4 DDX39B HSPB8 XRCC6 | 2.20e-05 | 341 | 137 | 11 | int:RPTOR |
| Interaction | VCAM1 interactions | EPRS1 ACAT1 RPS11 EWSR1 CHD4 XPO1 TUFM EEF1B2 EIF3B TALDO1 RPL4 DDX39B XRCC6 | 2.21e-05 | 475 | 137 | 13 | int:VCAM1 |
| Interaction | PABPC1 interactions | EPRS1 PARK7 RC3H1 WWP2 CHD4 SSB XPO1 HNRNPAB TUFM IGF2BP3 AHNAK SUPT16H EIF3B HERC2 RPL4 DDX39B | 2.21e-05 | 699 | 137 | 16 | int:PABPC1 |
| Interaction | ITGA4 interactions | EPRS1 ACAT1 RPS11 HMGB1 EWSR1 CHD4 XPO1 HNRNPAB ADAM28 EEF1B2 EIF3B RPL4 DDX39B XRCC6 | 2.22e-05 | 547 | 137 | 14 | int:ITGA4 |
| Interaction | RPLP2 interactions | IMPDH2 RC3H1 WWP2 RPS11 HMGB1 EWSR1 CHD4 SSB EEF1B2 IGF2BP3 EIF3B RPL4 | 2.36e-05 | 409 | 137 | 12 | int:RPLP2 |
| Interaction | RPL14 interactions | RC3H1 WWP2 UGGT1 RPS11 HMGB1 CHD4 SSB TUFM EEF1B2 IGF2BP3 AHNAK EIF3B RPL4 FTSJ3 | 2.55e-05 | 554 | 137 | 14 | int:RPL14 |
| Interaction | YWHAZ interactions | SORBS2 SASH1 PARK7 WWP2 SPTA1 SH2D3C DNAJB4 HMGB1 NCAM2 EWSR1 XPO1 RGS12 TUFM FAM83H EEF1B2 MCTP1 NUB1 ASXL2 GAPDHS MORC3 HERC2 CAMSAP2 XRCC6 | 2.72e-05 | 1319 | 137 | 23 | int:YWHAZ |
| Interaction | ZC3H18 interactions | EPRS1 RBBP6 RPS11 EXOSC1 HMGB1 EWSR1 CHD4 SSB HNRNPAB TUFM IGF2BP3 DDX50 SUPT16H PWP2 EIF3B RPL4 XRCC6 FTSJ3 | 2.82e-05 | 877 | 137 | 18 | int:ZC3H18 |
| Interaction | RPS13 interactions | RC3H1 WWP2 RPS11 HMGB1 CHD4 SSB GRIN2B XPO1 TUFM EEF1B2 IGF2BP3 EIF3B RPL4 | 2.99e-05 | 489 | 137 | 13 | int:RPS13 |
| Interaction | RPL19 interactions | IMPDH2 RC3H1 WWP2 RPS11 HMGB1 CHD4 SSB TUFM EEF1B2 IGF2BP3 DDX50 MRPL38 RPL4 XRCC6 FTSJ3 | 2.99e-05 | 638 | 137 | 15 | int:RPL19 |
| Interaction | NCL interactions | EPRS1 RC3H1 WWP2 RPS11 HMGB1 CHD4 SSB HNRNPAB RYR2 IGF2BP3 DDX50 ASXL2 HERC2 RPL4 DDX39B XRCC6 FTSJ3 | 3.01e-05 | 798 | 137 | 17 | int:NCL |
| Interaction | FBL interactions | RC3H1 WWP2 RPS11 CHD4 SSB XPO1 IGF2BP3 DDX50 SUPT16H PWP2 RPL4 XRCC6 PUS7 NOL8 FTSJ3 | 3.04e-05 | 639 | 137 | 15 | int:FBL |
| Interaction | RPS19 interactions | RC3H1 WWP2 RPS11 HMGB1 EWSR1 CHD4 SSB EEF1B2 DDX50 ASXL2 EIF3B HERC2 RPL4 XRCC6 FTSJ3 | 3.04e-05 | 639 | 137 | 15 | int:RPS19 |
| Interaction | ECT2 interactions | EPRS1 IMPDH2 VPS13C PARK7 RPS11 ACTR3 TUFM FAM83H POLR1F IGF2BP3 DDX50 AHNAK SUPT16H PWP2 NUB1 GNAL RPL4 XRCC6 | 3.27e-05 | 887 | 137 | 18 | int:ECT2 |
| Interaction | BAG1 interactions | IMPDH2 ACAT1 PARK7 RPS11 DNAJB4 SSB HNRNPAB PAICS ACTR3 TUFM RPL4 DDX39B XRCC6 | 3.32e-05 | 494 | 137 | 13 | int:BAG1 |
| Interaction | KRT2 interactions | 3.47e-05 | 236 | 137 | 9 | int:KRT2 | |
| Interaction | RPL11 interactions | RC3H1 WWP2 RPS11 HMGB1 CHD4 SSB TUFM EEF1B2 IGF2BP3 DDX50 SUPT16H EIF3B RPL4 HSPB8 FTSJ3 | 3.83e-05 | 652 | 137 | 15 | int:RPL11 |
| Interaction | SOD1 interactions | EPRS1 IMPDH2 ACAT1 PARK7 HMGB1 EWSR1 SSB HNRNPAB EEF1B2 PITPNB DDX39B XRCC6 | 3.93e-05 | 431 | 137 | 12 | int:SOD1 |
| Interaction | EIF6 interactions | WFS1 PARK7 RC3H1 WWP2 CHD4 BIRC6 PAICS HMGB1P1 EIF3B RPL4 NOL8 | 4.09e-05 | 365 | 137 | 11 | int:EIF6 |
| Interaction | MTDH interactions | RC3H1 WWP2 CYP27A1 CHD4 TUFM DDX50 FANCI SUPT16H PWP2 RPL4 XRCC6 EPHA8 FTSJ3 | 4.16e-05 | 505 | 137 | 13 | int:MTDH |
| Interaction | EWSR1 interactions | ERCC5 ACAT1 RBBP6 RC3H1 WWP2 HMGB1 SALL4 EWSR1 CHD4 SSB HNRNPAB EEF1B2 NTNG2 SUPT16H TALDO1 XRCC6 PACSIN2 PUS7 | 4.31e-05 | 906 | 137 | 18 | int:EWSR1 |
| Interaction | RPL22 interactions | RC3H1 WWP2 RPS11 HMGB1 CHD4 SSB EEF1B2 IGF2BP3 EIF3B HERC2 RPL4 FTSJ3 | 4.79e-05 | 440 | 137 | 12 | int:RPL22 |
| Interaction | RPL18 interactions | RC3H1 WWP2 RPS11 HMGB1 CHD4 SSB XPO1 EEF1B2 IGF2BP3 RPL4 DDX39B NOL8 FTSJ3 | 4.79e-05 | 512 | 137 | 13 | int:RPL18 |
| GeneFamily | Complement system|Sushi domain containing | 8.85e-04 | 36 | 95 | 3 | 492 | |
| GeneFamily | RNA binding motif containing | 9.06e-04 | 213 | 95 | 6 | 725 | |
| GeneFamily | Sterile alpha motif domain containing | 1.19e-03 | 88 | 95 | 4 | 760 | |
| GeneFamily | PDZ domain containing | 1.24e-03 | 152 | 95 | 5 | 1220 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | CRISPLD2 EPRS1 SASH1 SGCD HMGB1 HNRNPAB ACTR3 EEF1B2 FAT1 PTPN12 AHNAK C1S CAMSAP2 TALDO1 RPL4 DSE | 7.81e-07 | 681 | 140 | 16 | M39175 |
| Coexpression | GSE3400_UNTREATED_VS_IFNB_TREATED_MEF_DN | 1.01e-05 | 194 | 140 | 8 | M6134 | |
| Coexpression | GSE44955_MCSF_VS_MCSF_AND_IL27_STIM_MACROPHAGE_UP | 1.17e-05 | 198 | 140 | 8 | M9704 | |
| Coexpression | HALLMARK_MYC_TARGETS_V1 | 1.26e-05 | 200 | 140 | 8 | M5926 | |
| Coexpression | TSUDA_ALVEOLAR_SOFT_PART_SARCOMA | 1.74e-05 | 10 | 140 | 3 | M4000 | |
| Coexpression | GRADE_COLON_AND_RECTAL_CANCER_UP | 2.71e-05 | 290 | 140 | 9 | M16740 | |
| Coexpression | TRAVAGLINI_LUNG_PROXIMAL_BASAL_CELL | RNASEH2B EPRS1 IMPDH2 RPS11 HMGB1 ADAM28 RGS12 TUFM EEF1B2 AHNAK TALDO1 RPL4 XRCC6 | 3.43e-05 | 629 | 140 | 13 | M41652 |
| Coexpression | TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING | EPRS1 IMPDH2 ATRX ACAT1 PARK7 HMGB1 EWSR1 CHD4 SSB HNRNPAB NDUFC2 PAICS POLR1F EEF1B2 UBE2R2 EIF3B RPL4 DDX39B | 4.00e-05 | 1144 | 140 | 18 | MM3843 |
| Coexpression | TABULA_MURIS_SENIS_BLADDER_BLADDER_CELL_AGEING | 7.71e-05 | 332 | 140 | 9 | MM3679 | |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | SORBS2 PHF20 UBE4B HMGB1 GRIN2B MCTP1 SHANK2 PRKAG2 CFAP46 EPHA8 | 8.53e-05 | 417 | 140 | 10 | M39224 |
| Coexpression | GSE1925_CTRL_VS_24H_IFNG_STIM_MACROPHAGE_DN | 8.83e-05 | 195 | 140 | 7 | M6294 | |
| Coexpression | BHATTACHARYA_EMBRYONIC_STEM_CELL | 8.90e-05 | 84 | 140 | 5 | M4282 | |
| Coexpression | GSE37301_LYMPHOID_PRIMED_MPP_VS_PRO_BCELL_DN | 9.12e-05 | 196 | 140 | 7 | M8856 | |
| Coexpression | GSE1460_CORD_VS_ADULT_BLOOD_NAIVE_CD4_TCELL_UP | 9.42e-05 | 197 | 140 | 7 | M3480 | |
| Coexpression | GSE45365_HEALTHY_VS_MCMV_INFECTION_CD8A_DC_IFNAR_KO_DN | 1.00e-04 | 199 | 140 | 7 | M9970 | |
| Coexpression | GSE17721_0.5H_VS_8H_LPS_BMDC_UP | 1.00e-04 | 199 | 140 | 7 | M4074 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_POSITIVE | SASH1 KIAA0513 SGCD GAPT ITGAX HNRNPAB ACTR3 UBE2R2 TNFAIP2 PACSIN2 | 1.02e-04 | 426 | 140 | 10 | M41019 |
| Coexpression | GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_DN | 1.03e-04 | 200 | 140 | 7 | M3260 | |
| Coexpression | GSE360_CTRL_VS_L_MAJOR_MAC_UP | 1.03e-04 | 200 | 140 | 7 | M5160 | |
| Coexpression | GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 1.03e-04 | 200 | 140 | 7 | M9135 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 1.23e-04 | 276 | 140 | 8 | M3063 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | EPRS1 ATRX RBBP6 HAUS3 SSB PAICS POLR1F IGF2BP3 PTPN12 AHNAK SUPT16H DSE NOL8 | 1.35e-04 | 721 | 140 | 13 | M10237 |
| Coexpression | DIAZ_CHRONIC_MYELOGENOUS_LEUKEMIA_UP | PHF20 ATRX UBE4B ACAT1 SPTA1 UGGT1 HMGB1 SSB XPO1 HNRNPAB NDUFC2 PAICS ACTR3 PTPN12 SUPT16H PWP2 PITPNB EIF3B PACSIN2 | 1.69e-04 | 1399 | 140 | 19 | M535 |
| Coexpression | WEST_ADRENOCORTICAL_TUMOR_DN | CRISPLD2 MXRA5 SORBS2 ATRX WWP2 CHD4 AHNAK C1S TALDO1 PLXNB3 FTSJ3 | 1.75e-04 | 546 | 140 | 11 | M3837 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-07 | 184 | 139 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-07 | 184 | 139 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-07 | 184 | 139 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-07 | 191 | 139 | 8 | 7d1595e616f6f111fc2f5bc1b179c5d67d624cc9 | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.87e-07 | 195 | 139 | 8 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | facs-Skin-Anagen|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-06 | 189 | 139 | 7 | adbfc723130079b4caf551f66d2aee86fab1903c | |
| ToppCell | facs-Large_Intestine-Proximal-24m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 190 | 139 | 7 | 933c778bb8ec89621906fe7d484c1d2c6cd28d80 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.45e-06 | 192 | 139 | 7 | 4c9d748f209cc1e13d28c8c7f5180ab8522e0fbf | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 2.45e-06 | 192 | 139 | 7 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-06 | 194 | 139 | 7 | e74cd8cf3763f6adbfd1c269a886a806049714cf | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 2.62e-06 | 194 | 139 | 7 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | IPF-Multiplet-Multiplet|IPF / Disease state, Lineage and Cell class | 2.72e-06 | 195 | 139 | 7 | fce0c29574bb7aab181b9c00feb42681e285d1f2 | |
| ToppCell | IPF-Multiplet|IPF / Disease state, Lineage and Cell class | 2.72e-06 | 195 | 139 | 7 | eacc0449ae6f3ad8002268cd061467684c6fb9a7 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-06 | 195 | 139 | 7 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 2.81e-06 | 196 | 139 | 7 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 2.90e-06 | 197 | 139 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.90e-06 | 197 | 139 | 7 | 1da8ba5bbab232add6e43ad78b15c2339d0c2bc3 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.90e-06 | 197 | 139 | 7 | 82072bd73634e1ef24dc193e860af7786727313b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.90e-06 | 197 | 139 | 7 | b4869013f0523ac73c284e6cdaf64e9ae5213dc5 | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.00e-06 | 198 | 139 | 7 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.00e-06 | 198 | 139 | 7 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Enterocyte_Progenitors|World / shred on cell type and cluster | 3.10e-06 | 199 | 139 | 7 | 776bcc887927dea9ebd76ec4338ce2225c319c2c | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.10e-06 | 199 | 139 | 7 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.21e-06 | 200 | 139 | 7 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 160 | 139 | 6 | f2cdee5a9e3b0eb125d6be7b5d239eb04333ae41 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 169 | 139 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-05 | 176 | 139 | 6 | 6b4afd2c9268172063fe5832896bea15e862579e | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-cDC2|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.05e-05 | 178 | 139 | 6 | 32120936a524c38e621bd2fca17524fef74422e0 | |
| ToppCell | Hippocampus-Macroglia-POLYDENDROCYTE-P5|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 2.18e-05 | 180 | 139 | 6 | 44988c34861df359a68376500c42a64fbcc4b431 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.25e-05 | 181 | 139 | 6 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | 2.32e-05 | 182 | 139 | 6 | 354dcdb01360597f68c4fe157a682aee1c0b8bb1 | |
| ToppCell | facs-Thymus-Flowthrough|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 185 | 139 | 6 | c0587b32f9925052016a06422ddcdc2ad9b7fc93 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.54e-05 | 185 | 139 | 6 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.62e-05 | 186 | 139 | 6 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.62e-05 | 186 | 139 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 2.70e-05 | 187 | 139 | 6 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.78e-05 | 188 | 139 | 6 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease state, Lineage and Cell class | 2.87e-05 | 189 | 139 | 6 | c007fccd08728db3ea99af9da91d67b9b16dabb3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-05 | 189 | 139 | 6 | bfc76a72b600d641c8fe58346e5d8986c34f3981 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-05 | 190 | 139 | 6 | 876bd2eb9ed2624cb23bdcf6b989e4fa34d099e3 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.95e-05 | 190 | 139 | 6 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell_of_renal_cortex-lymphatic_endothelial_cell_of_renal_cortex|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-05 | 190 | 139 | 6 | be9f36127028f52ca5fc1b32ba15a6c26aad69ac | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Endothelial-lymphatic_endothelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.95e-05 | 190 | 139 | 6 | 09a8855901c3c9332dbaab3e40166485b696d0f1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Degenerative_Outer_Medullary_Collecting_Duct_Principal_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.04e-05 | 191 | 139 | 6 | 7235a4d1601c88a2c8af571a2c04ab56d32f1b9a | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.04e-05 | 191 | 139 | 6 | 4e4488380379ed29d7898bae4e24221e7c67eb9d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.13e-05 | 192 | 139 | 6 | c4efc170852abbcf0c53c2b0f8a0cc9fe7f116c8 | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 3.13e-05 | 192 | 139 | 6 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 3.13e-05 | 192 | 139 | 6 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.22e-05 | 193 | 139 | 6 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.22e-05 | 193 | 139 | 6 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.22e-05 | 193 | 139 | 6 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 3.22e-05 | 193 | 139 | 6 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.22e-05 | 193 | 139 | 6 | 5de87fc94a6e58899ef4124cf4887ed3ff96163a | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.32e-05 | 194 | 139 | 6 | 69362e13158033de44f90f3773db6c0f27de8cb3 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.42e-05 | 195 | 139 | 6 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 3.42e-05 | 195 | 139 | 6 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.42e-05 | 195 | 139 | 6 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.42e-05 | 195 | 139 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | control-Others-CD34+_GATA2+_cells|Others / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 3.52e-05 | 196 | 139 | 6 | 25994ca143701c72d2f84a3b6d348fcfa1d26a54 | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 3.52e-05 | 196 | 139 | 6 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.52e-05 | 196 | 139 | 6 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.52e-05 | 196 | 139 | 6 | ee45e4de9d706ec87094e87f47d3e514539b8092 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.52e-05 | 196 | 139 | 6 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 3.52e-05 | 196 | 139 | 6 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.52e-05 | 196 | 139 | 6 | fa4a85a3cd52df0da5dfedc0e584e9df8c61ce89 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.52e-05 | 196 | 139 | 6 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.52e-05 | 196 | 139 | 6 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 3.62e-05 | 197 | 139 | 6 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-05 | 197 | 139 | 6 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.62e-05 | 197 | 139 | 6 | ea746772adb9df4ddb0508d4ef35f2027bf09c35 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-05 | 197 | 139 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_2|COVID-19_Mild / Disease condition and Cell class | 3.62e-05 | 197 | 139 | 6 | e844f660010d114d65bd814f3d3fccd8e4a6b8da | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 3.62e-05 | 197 | 139 | 6 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.62e-05 | 197 | 139 | 6 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.72e-05 | 198 | 139 | 6 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 3.72e-05 | 198 | 139 | 6 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.72e-05 | 198 | 139 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | (2)_MNPs-(2)_Dendritic_Cells|(2)_MNPs / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 3.72e-05 | 198 | 139 | 6 | 4c1f155298b7d0afddfeb2744b369a1ffd823916 | |
| ToppCell | NS-critical-d_0-4-Myeloid|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.72e-05 | 198 | 139 | 6 | 72d51284d267f102c26f0ae8279ee9e11e69c7e3 | |
| ToppCell | Immune_cells-large_pre-B.|Immune_cells / Lineage and Cell class | 3.72e-05 | 198 | 139 | 6 | bc9ceefadb153907d2854d1f736d17349003cb31 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.72e-05 | 198 | 139 | 6 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.72e-05 | 198 | 139 | 6 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | metastatic_Brain-Fibroblasts-FB-like_cells|metastatic_Brain / Location, Cell class and cell subclass | 3.83e-05 | 199 | 139 | 6 | 12133087eae9f0e9b6c13a71e8187117768e64ce | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 3.83e-05 | 199 | 139 | 6 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | HSPCs|World / Lineage and Cell class | 3.83e-05 | 199 | 139 | 6 | df1ffc416c6946f1ba182f242a50ee41a571d565 | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 3.83e-05 | 199 | 139 | 6 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| ToppCell | critical|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.83e-05 | 199 | 139 | 6 | 16c55cb8a0e740342009965f0eddfb0ed2858fab | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 3.83e-05 | 199 | 139 | 6 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.83e-05 | 199 | 139 | 6 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 3.83e-05 | 199 | 139 | 6 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.83e-05 | 199 | 139 | 6 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 3.83e-05 | 199 | 139 | 6 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | NS-critical|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.83e-05 | 199 | 139 | 6 | f7c14dc9a9e659f89352dccf8954d6cbada011ab | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.93e-05 | 200 | 139 | 6 | e504570fd7eec1524c401b1cfa9d10822d80d994 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 3.93e-05 | 200 | 139 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.93e-05 | 200 | 139 | 6 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.93e-05 | 200 | 139 | 6 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | supra_basal_cell|World / shred by cell class for nasal brushing | 3.93e-05 | 200 | 139 | 6 | 542bdcec563644e01887fd85eb158b32db439b03 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.93e-05 | 200 | 139 | 6 | 8f585920bf7ad8bb489c78e2db42435962de4416 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Stem_cells-neuroepithelial-like_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 4.92e-05 | 127 | 139 | 5 | 9071cd0953c8bb6746dc9cd13d153e3d6ef40b08 | |
| Computational | Neighborhood of APEX1 | 5.94e-07 | 92 | 85 | 8 | GNF2_APEX1 | |
| Computational | Neighborhood of RAD23A | EPRS1 ERCC5 PARK7 CHD4 SSB XPO1 HNRNPAB ACTR3 TUFM EIF3B DDX39B XRCC6 | 1.72e-05 | 348 | 85 | 12 | MORF_RAD23A |
| Computational | Genes in the cancer module 32. | 1.91e-05 | 241 | 85 | 10 | MODULE_32 | |
| Computational | Neighborhood of BUB3 | 6.25e-05 | 277 | 85 | 10 | MORF_BUB3 | |
| Computational | Neighborhood of XRCC5 | 9.51e-05 | 235 | 85 | 9 | MORF_XRCC5 | |
| Computational | Neighborhood of EIF3S2 | 1.35e-04 | 246 | 85 | 9 | MORF_EIF3S2 | |
| Computational | Neighborhood of FBL | 1.51e-04 | 146 | 85 | 7 | GNF2_FBL | |
| Computational | Neighborhood of PCNA | 4.92e-04 | 83 | 85 | 5 | MORF_PCNA | |
| Computational | Neighborhood of UBE2I | 5.69e-04 | 238 | 85 | 8 | MORF_UBE2I | |
| Computational | Neighborhood of GNB1 | 6.58e-04 | 305 | 85 | 9 | MORF_GNB1 | |
| Computational | Neighborhood of DENR | 6.86e-04 | 51 | 85 | 4 | GNF2_DENR | |
| Computational | Neighborhood of FBL | 8.25e-04 | 140 | 85 | 6 | MORF_FBL | |
| Computational | Neighborhood of UBE2N | 9.11e-04 | 95 | 85 | 5 | MORF_UBE2N | |
| Computational | Neighborhood of DEK | 1.12e-03 | 58 | 85 | 4 | GNF2_DEK | |
| Computational | Neighborhood of AATF | 1.30e-03 | 209 | 85 | 7 | MORF_AATF | |
| Computational | Neighborhood of ACP1 | 1.37e-03 | 211 | 85 | 7 | MORF_ACP1 | |
| Computational | Neighborhood of SMC1L1 | 1.43e-03 | 62 | 85 | 4 | MORF_SMC1L1 | |
| Computational | Genes in the cancer module 229. | 1.83e-03 | 31 | 85 | 3 | MODULE_229 | |
| Disease | reticulocyte count | EPRS1 DNAH10 CYP19A1 SPTA1 CYP27A1 HMGCL ITGAX BIRC6 HNRNPAB HMGB1P1 EEF1B2 ZNF800 FAT1 SGPL1 AHNAK ASXL2 HERC1 DDX39B | 2.17e-06 | 1045 | 139 | 18 | EFO_0007986 |
| Disease | reticulocyte measurement | DPY19L3 DNAH10 ACAT1 SPTA1 ITGAX BIRC6 HNRNPAB HMGB1P1 EEF1B2 UBE2R2 ZNF800 FAT1 SGPL1 AHNAK ASXL2 DDX39B | 3.84e-05 | 1053 | 139 | 16 | EFO_0010700 |
| Disease | autosomal dominant limb-girdle muscular dystrophy type 1 (implicated_via_orthology) | 1.31e-04 | 4 | 139 | 2 | DOID:0110305 (implicated_via_orthology) | |
| Disease | congenital myopathy 21 (implicated_via_orthology) | 1.31e-04 | 4 | 139 | 2 | DOID:0081353 (implicated_via_orthology) | |
| Disease | odorant-binding protein 2b measurement | 2.18e-04 | 5 | 139 | 2 | EFO_0801859 | |
| Disease | carbohydrate metabolic disorder (is_implicated_in) | 2.18e-04 | 5 | 139 | 2 | DOID:2978 (is_implicated_in) | |
| Disease | Intellectual Disability | 2.80e-04 | 447 | 139 | 9 | C3714756 | |
| Disease | Disorder of eye | 5.21e-04 | 212 | 139 | 6 | C0015397 | |
| Disease | placental insufficiency (biomarker_via_orthology) | 6.06e-04 | 8 | 139 | 2 | DOID:3891 (biomarker_via_orthology) | |
| Disease | Hodgkins lymphoma | 6.20e-04 | 82 | 139 | 4 | EFO_0000183 | |
| Disease | obsolete_red blood cell distribution width | DPY19L3 AHI1 RC3H1 SPTA1 CHD4 ITGAX BIRC6 HMGB1P1 ZNF800 FANCI SGPL1 C1S ASXL2 RP1 HERC1 PRKAG2 | 6.25e-04 | 1347 | 139 | 16 | EFO_0005192 |
| Disease | cholesteryl ester 16:0 measurement | 6.52e-04 | 36 | 139 | 3 | EFO_0010341 | |
| Disease | alkaline phosphatase measurement | PSKH1 WWP2 CYP19A1 DNAJB4 LCN1P1 UBE2R2 ZNF800 NTNG2 SAG AHNAK RP1 TNKS2 EPHA8 | 1.05e-03 | 1015 | 139 | 13 | EFO_0004533 |
| Disease | Squamous cell carcinoma of esophagus | 1.08e-03 | 95 | 139 | 4 | C0279626 | |
| Disease | trypsin-3 measurement | 1.18e-03 | 11 | 139 | 2 | EFO_0020791 | |
| Disease | glycerophosphorylcholine measurement | 1.18e-03 | 11 | 139 | 2 | EFO_0020018 | |
| Disease | Amelogenesis Imperfecta | 1.41e-03 | 12 | 139 | 2 | C0002452 | |
| Disease | Neurobehavioral Manifestations | 1.41e-03 | 12 | 139 | 2 | C0525041 | |
| Disease | schizophrenia (biomarker_via_orthology) | 2.22e-03 | 15 | 139 | 2 | DOID:5419 (biomarker_via_orthology) | |
| Disease | maximal oxygen uptake measurement, response to exercise | 2.53e-03 | 16 | 139 | 2 | EFO_0004887, EFO_0007768 | |
| Disease | Abnormal behavior | 2.53e-03 | 16 | 139 | 2 | C0233514 | |
| Disease | colorectal cancer (is_implicated_in) | 2.62e-03 | 121 | 139 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | protein-glutamine gamma-glutamyltransferase e measurement | 2.88e-03 | 60 | 139 | 3 | EFO_0020690 | |
| Disease | cutaneous melanoma, hair color | 3.16e-03 | 62 | 139 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | Disorder of organic acid metabolism | 3.21e-03 | 18 | 139 | 2 | cv:C1263739 | |
| Disease | Hydrops Fetalis | 3.57e-03 | 19 | 139 | 2 | C0020305 | |
| Disease | Profound Mental Retardation | 4.30e-03 | 139 | 139 | 4 | C0020796 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 4.30e-03 | 139 | 139 | 4 | DOID:3908 (is_implicated_in) | |
| Disease | Mental Retardation, Psychosocial | 4.30e-03 | 139 | 139 | 4 | C0025363 | |
| Disease | Mental deficiency | 4.30e-03 | 139 | 139 | 4 | C0917816 | |
| Disease | nephrotic syndrome | 4.63e-03 | 71 | 139 | 3 | EFO_0004255 | |
| Disease | mean reticulocyte volume | 4.66e-03 | 799 | 139 | 10 | EFO_0010701 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GEYEVIFKEQLSPKK | 321 | Q8NAT2 | |
| YLDKETGKPKGDATV | 401 | Q01844 | |
| PVVDESGKVVDIYSK | 461 | Q9UGJ0 | |
| KEIAEAYDVLSDPKK | 46 | O75953 | |
| KAAAAEAKYIEKGSP | 661 | P0C7U0 | |
| EAKYIEKGSPAADAI | 666 | P0C7U0 | |
| KITNDFYPEEDGKTK | 216 | P55884 | |
| VTDYGKDLMEKVKSP | 41 | P02652 | |
| YVATVEDEAAAAKKP | 2181 | Q9NR09 | |
| KKKAAAYPAAENTEI | 51 | Q9UBJ2 | |
| VSAIKELPGVKKYEV | 16 | Q9UKQ2 | |
| KEIKETEFKGIPISY | 791 | Q8N157 | |
| GAEAPAKKDVKGSYV | 26 | Q13838 | |
| AGTEEQKAKYLPKLA | 156 | Q9H845 | |
| AYEKPKFITAAKGKV | 2186 | Q8IYW2 | |
| GSYIKDGPKKSDTDI | 121 | Q8WTQ4 | |
| VKGTKVKGEYDVTVP | 706 | Q09666 | |
| PKKAEDSAPGKIQYE | 401 | Q8N283 | |
| VDPDLVKGKKVYVTL | 51 | P10523 | |
| IYAGDVDVGKKKADI | 441 | Q9BWV3 | |
| KMEKGTVDLKPETAY | 451 | Q6ZPD9 | |
| KEPAYKAVVTEGKIY | 161 | Q9H4D0 | |
| YTLKKDVPDGVKELS | 81 | Q76L83 | |
| YIGTKDAKPKDVVAA | 821 | Q5TC82 | |
| KKEGDSLDYKDVIPM | 261 | P20702 | |
| TAYSPEDEKKGEKIY | 276 | O60268 | |
| PYTDENKKVGLALKD | 26 | Q9Y5A7 | |
| KAGPVKFEKDVYRAE | 361 | Q14517 | |
| DSYGPKKVLDGKTIE | 391 | Q9NVI1 | |
| KVGNADVPDYSLLKK | 626 | Q9Y5Z7 | |
| TSDPYVKFKIGGKEV | 281 | Q6DN14 | |
| EVKPGKVAYESGSKL | 46 | Q86UL8 | |
| EKDIAAYRAKGKPDA | 156 | P09429 | |
| KFVETPGQKYKETDL | 166 | P05455 | |
| KKDEEETPAPIYRAK | 81 | O95714 | |
| KPEELMVKTKDGYVE | 106 | Q9UJY1 | |
| KVKKYEQGFITDPVV | 106 | P12268 | |
| GAKLRPNYDKSEVEK | 3346 | Q15751 | |
| PNYDKSEVEKKGPLE | 3351 | Q15751 | |
| VKKVEPFSGTKSDVY | 21 | P11801 | |
| EVKVILEKTDEPGKY | 81 | Q5VSP4 | |
| VKEKVLDQVYKGTPF | 1551 | Q9ULL4 | |
| IPEDLDEITGKKGYK | 221 | Q14149 | |
| ASLEDAKKEGPYDVV | 56 | Q99497 | |
| PNDGDEKYEKTIIKS | 231 | Q9BRP1 | |
| DVDVMPVDKKKTYVG | 456 | Q9H0B8 | |
| PKAKGKTDKELYENT | 101 | Q8N292 | |
| PEEDKKTYGEIFEKF | 101 | O95298 | |
| EVKAVLEKTDEPGKY | 81 | P31025 | |
| AIKSSIVPEVKDYAA | 726 | Q9UL01 | |
| TEKDKVEIYKSFRPG | 111 | Q9Y3B2 | |
| GAKFKKYEEIDNAPE | 86 | P49411 | |
| IKEETYRVETVKPGK | 1056 | Q76FK4 | |
| IIKEKQDGSKYPELA | 181 | Q9Y5G0 | |
| PLVVEDKVEGYKKTK | 151 | P36578 | |
| YGKIKEENFVSPKEE | 471 | O00425 | |
| PTIDAEAYAIGKKEK | 221 | Q7Z6E9 | |
| EVLKNEPYEKDGEKG | 41 | P48739 | |
| EKVLAGKSKIEDYFP | 286 | P38405 | |
| KPREDEKDGQAYKFV | 376 | Q9NZW5 | |
| EKYEKSLKELDQGTP | 206 | Q9UNF0 | |
| FIGDEAIEKPTYATK | 61 | P61158 | |
| KTEDKDKPLIYKGEG | 2061 | P46100 | |
| KEVAEAYEVLSDPKK | 46 | Q9UDY4 | |
| AISEKYGLPVEKIAK | 566 | Q6ISB3 | |
| KALEDDVIDGYPVKK | 376 | P11511 | |
| DVPVAIKALKAGYTE | 661 | P29322 | |
| KYKVVLAPETGELKS | 496 | Q02318 | |
| LPNGDIDEYEKKSKR | 96 | Q9BQ39 | |
| KEVKVEKPTADAEAY | 596 | P09871 | |
| EFVETLKKIGYPKAD | 6 | Q68CZ6 | |
| EKLELTKYADKPAGT | 2171 | Q9BZC7 | |
| VDAQPKKESYKVGDV | 156 | Q9BXR6 | |
| EYKPQKEVDRGKTVS | 4496 | Q8NDH2 | |
| SYEKEKASLPGVKKA | 61 | P24534 | |
| STKVAELLEKYKGPA | 731 | Q6ZRV2 | |
| PYSAIKEAVKAAAKG | 326 | O14556 | |
| KKKKGEEEVTAVDGY | 351 | Q14839 | |
| NKEVDYKIPVGDEKE | 4126 | Q8IVF4 | |
| YKIPVGDEKEKFVEA | 4131 | Q8IVF4 | |
| ISAVDVKPKDEAALY | 366 | Q9UJQ4 | |
| TFKEYDPDGKGVISK | 4031 | Q92736 | |
| KADVPVEKYDGESDK | 1136 | Q08AD1 | |
| KEYVSKKALPEEAPA | 906 | Q9BVI0 | |
| AAEKSGPEKKLVYQE | 1041 | P56715 | |
| LKDYVKVKVEPSGIT | 46 | Q96CW9 | |
| TPKEAIEGTYIDKKC | 46 | P62280 | |
| TKPVLGKDEDFKQYV | 631 | P07814 | |
| GSKCEIKVAQPKEVY | 221 | Q99729 | |
| AVPSEVDVEKLAKGY | 301 | Q3ZLR7 | |
| EYKPGKALSETELKN | 801 | A5PKW4 | |
| SPEVKEAYGEKFVAD | 231 | O75452 | |
| YPGSSKDDVIEKGSK | 596 | Q8NE09 | |
| YEGKISPAKVAEVTK | 176 | P35914 | |
| AVAEAYLKPVVDDSK | 931 | P28715 | |
| EKDIAAYQAKGKPEA | 156 | B2RPK0 | |
| KIYPTATGEKEENVK | 46 | Q05209 | |
| PGLETKTEDREGKKY | 216 | Q96PZ0 | |
| VTKKKPKAEGYAEGD | 231 | Q8IY81 | |
| SQGPEERSEYLKKVK | 306 | Q9Y6H5 | |
| IEKAGIPKEEVKEAY | 76 | P24752 | |
| KIVVYKEAEKSPQLG | 271 | Q9P2S5 | |
| PSIVKVYDECKEGVA | 726 | Q96JS3 | |
| EEKKYLAGADPSTVE | 226 | Q9Y5B9 | |
| LTNKEGKKPEEKTYA | 386 | Q9Y5B9 | |
| VVKKNTKGAEDYPDP | 996 | O94875 | |
| LKVDKEYVKALPSQG | 106 | O95470 | |
| EVGKIASKAVYVPAK | 991 | Q9UPX8 | |
| AVPSEVDVEKLAKGY | 301 | P0C7V6 | |
| YKKKLVEGDLSSPEA | 146 | Q9NQW8 | |
| GKTKEVYELLDSPGK | 16 | P22234 | |
| GSKRPKVEYSEEELK | 551 | P12956 | |
| DPTCVEKEKVYIGKL | 116 | O14980 | |
| GAAPYREEEEAAKKK | 16 | Q03169 | |
| YVEVAVDGLPSETKK | 41 | O00308 | |
| EYFGEKTDPKEKIDI | 76 | Q96DV4 | |
| DKAGVVAEYPAEKLA | 286 | O14924 | |
| EQIEKIYPKVTGKDF | 491 | Q8N427 | |
| GKAAYLKDGSKEPIV | 756 | O15394 | |
| VTEEKGNPEIDNKKY | 141 | Q5TBB1 | |
| TGPKAVEAYGKKFEV | 126 | Q92629 | |
| ATPAEEEKTGKVKYS | 261 | Q15269 | |
| AEDDVKVVEKYFSGP | 601 | O95155 | |
| EAKKYASRVGPEQKV | 771 | Q9H269 | |
| TVTVEDLEPGKKYKF | 3501 | P22105 | |
| EGDFVYKEVIKSPTA | 431 | O94885 | |
| VPGASIKYDAVKEEK | 91 | Q709C8 | |
| KEKEPVLTSEDYGKD | 281 | P02549 | |
| PEEKKEGEKSAYSVF | 141 | Q9NPB0 | |
| KKKDPETYEVDSGTT | 231 | Q3B726 | |
| PSAKAVLTGEYKKDE | 166 | Q9H2K2 | |
| PSKKYEVADVGIEVK | 596 | Q2TB10 | |
| EPEAGSDYVKFSKEK | 176 | Q8N5H7 | |
| TDKKSYEPLEDPGVK | 201 | P37837 | |
| AEKDGVKVPTTLAEY | 176 | Q712K3 | |
| KKDDGLQYRPDVKDA | 246 | Q8IYR6 | |
| DKVKDGGYRPAEDKI | 506 | O96006 | |
| KIDFVISEYGSKDKP | 121 | P0C672 | |
| ISEYGSKDKPEDITK | 126 | P0C672 | |
| IAEAEEDKIKKTYPP | 46 | Q8WXD2 | |
| GKTDEPKGKTEAYLE | 396 | Q8WXD2 | |
| KETGALYKEKTKEPS | 1531 | Q9NYU2 | |
| DFVEITKKYAKGVIP | 246 | O76024 | |
| APIVSKTKEGKYRVD | 326 | P48048 | |
| TYKPTSDGKEIKDDV | 1316 | Q9NR99 | |
| VTENKTDEEPGYIKK | 441 | Q13224 |